AzTrials
AzTrials

Mask VentilationMASCANNCT05411406

Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning

An observational study of Mask Ventilation and General Anesthesia, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to prove feasibility and assess the diagnostic performance of a machine learning algorithm that relies on data from 3D-face scans with predefined motion-sequences and scenes (MASCAN algorithm), together with patient-specific meta-data for the prediction of difficult mask ventilation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mask Ventilation, General Anesthesia
How many people
423 participants
Where
1 siteGermany
Study dates
7 Nov 2022to 15 May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Consecutive sampling: Adult patients that undergo ENT or OMS surgery in a tertiary care hospital who require facemask ventilation and tracheal intubation after induction of anesthesia.

Who may be able to join

  • Patients scheduling for ENT or OMS surgery in general anaesthesia, who require facemask ventilation and tracheal intubation after induction of anesthesia
  • Patients aged at least 18 years
  • Ability to understand the patient information and to personally sign and date the informed consent to participate in the study
  • The patient is co-operative and available for the entire study
  • Provided informed consent/patient representative

Who cannot join

  • Pregnant or breastfeeding woman
  • Rapid sequence induction or other contraindications for facemask ventilation
  • Planned awake tracheal intubation

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Medical Center Hamburg-Eppendorf

    Hamburg, 20246

Other trials in Germany

About this study

Official title: Proof-of-principle Study for the Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning

The aim of this study is to prove feasibility and assess the diagnostic performance of a machine learning algorithm that relies on data from 3D-face scans with predefined motion-sequences and scenes (MASCAN algorithm), together with patient-specific meta-data for the prediction of difficult mask ventilation. A secondary aim of the study is to verify whether voice and breathing scans improve the performance of the algorithm. From the clinical point of view, we believe that an automated assessment would be beneficial, as it preserves time and health-care resources while acting observer-independent, thus providing a rational, reproducible risk estimation.

Keywords
Risk prediction, Airway management

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05411406
Study groupRoleWhat they receive
Study cohortPatients undergoing ENT or OMS surgery with general anesthesia with facemask ventilation and tracheal intubation (observational)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difficult facemask ventilation

    Observed difficult facemask ventilation after induction of anesthesia

    Measured: 1 hour

Secondary outcomes (16)
  1. Difficult tracheal intubation

    Observed difficult intubation after induction of anesthesia

    Measured: 1 hour

  2. Difficult laryngoscopy

    Observed difficult laryngoscopy after induction of anesthesia

    Measured: 1 hour

  3. Number of attempts

    Observed during tracheal intubation

    Measured: 1 hour

  4. Failed direct laryngoscopy

    Observed during airwaymanagement

    Measured: 1 hour

  5. Cormack Lehane grade

    Grading of the best view obtained during laryngoscopy (I-IV)

    Measured: 1 hour

  6. Difficult mask ventilation alert

    Noted by the responsible anaesthesiologist after airway management

    Measured: 1 hour

  7. Difficult intubation alert

    Noted by the responsible anaesthesiologist after airway management

    Measured: 1 hour

  8. Intubation time

    Recorded during airwaymanagement

    Measured: 1 hour

  9. Time to sufficient mask ventilation

    Recorded during airwaymanagement

    Measured: 1 hour

  10. Classification of intubation difficulty

    VIDIAC score rating between -1 and 5 points

    Measured: 1 hour

  11. Percentage of glottis opening (POGO)

    Grading of the best view obtained during laryngoscopy (%)

    Measured: 1 hour

  12. Impossible facemask ventilation

    Observed impossible facemask ventilation after induction of anesthesia

    Measured: 1 hour

  13. Successful first attempt intubation

    Observed during airway management

    Measured: 1 hour

  14. Airway-related adverse events

    Laryngospasm, bronchospasm, larynx trauma, airway trauma, soft tissue trauma, oral bleeding, edema, dental damage, corticosteroid application, accidental esophageal intubation, aspiration, hypotension or hypoxia

    Measured: 1 hour

  15. Post-intubation recommendation for an intubation method

    Recommendation of the responsible anaesthesiologist after airwaymanagement

    Measured: 1 hour

  16. Minimal peripheral oxygen saturation (SpO2)

    Observed after induction of anesthesia

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2022
  2. Study start7 Nov 2022
  3. Primary completion15 May 2023
  4. Study completion15 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
423 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05411406
Sponsor's protocol ID
2022-100811-BO-ff
Acronym
MASCAN
Status last verified
Sep 2023
First submitted
6 Jun 2022
Last updated
26 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mask Ventilation and General Anesthesia, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difficult facemask ventilation (time frame: 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in